research use only
Cat.No.P1094
Amino-acid Sequence
CAS No. 934016-19-0
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
| Storage (From the date of receipt) | 3 years-20°C powder | ||
|
In vitro |
DMSO
: 33 mg/mL
;
Water : 33 mg/mL Ethanol : Insoluble |
Molecular Weight Calculator |
|
In vivo Add solvents to the product individually and in order. |
In vivo Formulation Calculator |
||||
| Description | Degarelix acetate (ASP-3550 acetate) is a potent and long-acting luteinizing hormone-releasing hormone (LHRH) antagonist. |
|---|
In Vivo |
||
| In vivo |
Degarelix acetate is a member of a new class of long-acting gonadotropin-releasing hormone (GnRH) antagonists, possessing a long duration of luteinizing hormone (LH) and testosterone suppression. |
|
|---|---|---|
| Animal Research | Animal Models | castrated male rat model |
| Dosages | 50 μg | |
| Administration | -- | |
References |
|
| Molecular Formula | C82H103ClN18O16.C2H4O2 |
|---|---|
| Molecular Weight | 1632.26(free base) |
| CAS No. | 934016-19-0 |
| Appearance | White Powder |
| Peptide Content (by %N) | ≥80% |
| Single Impurity (by HPLC) | ≤1.0% |
| Assay (By Anhydrous, Acetic Acid-free) | 95.0~105.0% |
| MS | Consistent |
| Packing | plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement. |
| Storage (From the date of receipt) |
3 years-20°C powder |
| Shipping | Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.) |